Moneycontrol
SENSEX NIFTY

Dr Agrawals Eye Hospital

BSE: 526783|ISIN: INE934C01018|SECTOR: Hospitals & Medical Services
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 10:37
680.00
-5.8 (-0.85%)
VOLUME 5
Dr Agrawals Eye Hospital is not listed on NSE
Announcements on Dr Agarwals Eye

27th-Nov-2017 12:54Source: BSE

Dr Agrawals Eye Hospital- Newspaper Publication

We wish to inform you that the Unaudited Financial Results for the Quarter and half year ended 30/09/2017 was published in Business Standard and Makkal Kural on 23rd November 2017. We are enclosing he...

22nd-Nov-2017 13:12Source: BSE

Dr Agrawals Eye Hospital- Updates

Dear Sir,

In supersession of the earlier authorization given to Mrs. Hema Pasupatheeswaran, Company Secretary, the Board has, at its meeting held on 22nd November 2017, authorized either Mr.R...

22nd-Nov-2017 13:04Source: BSE

Dr Agrawals Eye Hospital- Appointment of Company Secretary / Compliance Officer

We would like to inform you that the Board meeting held today, the Board of Directors approved the appointment of Mr.S. Lakshmi Narasimhan, as the Company Secretary at its meeting held on 22nd Novembe...

22nd-Nov-2017 12:58Source: BSE

Dr Agrawals Eye Hospital- Unaudited Results For The Quarter And First Half Year Ended 30/09/2017

We would like to inform you that the Board meeting held today, the Board of Directors approved the un-audited results of the company for the second quarter ended 30th September, 2017. A copy of the U...

8th-Nov-2017 12:42Source: BSE

Dr Agrawals Eye Hospital- Intimation Regarding Board Meeting On 22Nd November,2017

We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on the Wednesday, 22nd November, 2017, at the Registered Office of the Company to consider a...

23rd-Oct-2017 14:27Source: BSE

Dr Agrawals Eye Hospital- Compliance Certificate As Per Regulation 40(9) Of The SEBI LODR For The Half Year Ended September 30,2017.

We are enclosing herewith the Compliance Certificate as per Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by a Practicing Company Secretary fo...

17th-Oct-2017 11:32Source: BSE

Dr Agrawals Eye Hospital- Shareholding for the Period Ended September 30, 2017

Dr Agarwals Eye Hospital Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

16th-Oct-2017 14:29Source: BSE

Dr Agrawals Eye Hospital- Statement Pursuant To Regulation 13(3) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Quarter Ended 30Th September 2017.

Information from the RTA on the number of investor complaints and other correspondence for the Quarter ended 30th September, 2017.

16th-Oct-2017 11:56Source: BSE

Dr Agrawals Eye Hospital- Compliance Certificate As Per Regulation 7(3) Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September ,2017

With reference to the above, please find attached the Compliance Certificate as per Regulation 7 (3) of SEBI Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regula...

9th-Oct-2017 19:01Source: BSE

Dr Agarwals Eye- Compliance Certificate As Per Regulation 7(3) Of The SEBI LODR, 2015 For The Half Year Ended 30Th September 2017.

With reference to the above, please find attached the Compliance Certificate as per Regulation 7 (3) of SEBI Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regula...

1 2 3 4 5 Next >>
Quick Links for Dr Agrawals Eye Hospital
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.